June 14, 2026 04:21 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Tragedy in the skies: Five IAF personnel killed in AN-32 crash in Assam | 'Ask probe officers whether I hid anything': Abhishek Banerjee hits back after pre-dawn police search | Police storm Abhishek Banerjee's house at 3 am tracking aide, Mamata arrives; seizure list says 'NIL' | Big boost for India's security: DRDO successfully tests advanced missile shield | Indian-origin man jailed for 34 years in UK over horrific kidnap, torture and rape case | Mamata's nightmare deepens! Saayoni Ghosh, Dev, Rachana Banerjee among 19 rebel MPs seeking TMC split | Trump claims US 'ended war with Iran', Tehran yet to confirm a deal | Heartbreak for Indian sports: Manu Bhaker's mentor Jaspal Rana passes away at 49 | Three Indian seafarers, missing after US strike on tanker near Oman, confirmed dead | 'Choose your side': TMC MP Kalyan Banerjee's ultimatum to Mamata in open revolt against Abhishek
Remdesivir
Image Credit: Unsplash

Remdesivir prices to go below Rs 3,500, assures minister: Report

| @indiablooms | Apr 15, 2021, at 12:37 am

New Delhi/IBNS: Union minister Mansukh Mandaviya said on Wednesday that the manufacturers of Remdesivir have decided to reduce the price of the anti-viral drug to less than Rs 3,500 by the end of the current week, said media reports.

This comes as India faces an acute shortage of the life-saving drug in the wake of the huge spike in Covid-19 cases, said an HT report. 

Currently, remdesivir prices are not uniform, and ranges between Rs 900 and Rs 5,000 per vial, the report added.

On April 11, India banned the export of antiviral drug Remdesivir and and Remdesivir Active Pharmaceutical Ingredients (API) due to massive jump in coronavirus cases in the country.

India is witnessing a recent surge in COVID cases. As on 11.04.2021, there are 11.08 lakh active COVID cases and they are steadily increasing. This has led to a sudden spike in demand for Injection Remdesivir used in the treatment of COVID patients. There is a potential of a further increase in this demand in the coming days,” the government had said in an order.

The order stated that  seven Indian companies are producing Remdesivir injection under a voluntary licensing agreement with US company Gilead Sciences. They have an installed capacity of about 38.80 lakh units per month.

"In light of the above, the Government of India has prohibited the exports of Injection Remdesivir and Remdesivir Active Pharmaceutical Ingredients (API) till the situation improves,"  the statement added.

All domestic manufactures of Remdesivir have been advised to display on their website, details of their stockists/distributors to facilitate access to the drug, the statement said.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.